Tobacco Use Disorder Clinical Trials

30 recruitingLast updated: June 18, 2026

There are 30 actively recruiting tobacco use disorder clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3. Top locations include Charleston, South Carolina, United States, Toronto, Ontario, Canada, Columbia, Missouri, United States. Updated daily from ClinicalTrials.gov.


Tobacco Use Disorder Trials at a Glance

30 actively recruiting trials for tobacco use disorder are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 13 trials, with the heaviest enrollment activity in Charleston, Toronto, and Columbia. Lead sponsors running tobacco use disorder studies include Medical University of South Carolina, Johns Hopkins University, and Centre for Addiction and Mental Health.

Browse tobacco use disorder trials by phase

Treatments under study

About Tobacco Use Disorder Clinical Trials

Looking for clinical trials for Tobacco Use Disorder? There are currently 29 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tobacco Use Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tobacco Use Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Not Applicable

Young Adult Tobacco/Nicotine and Cannabis Co-use

Tobacco Use DisorderNicotine Dependence
Medical University of South Carolina350 enrolled1 locationNCT06239350
Recruiting
Phase 4

E-cigarette Cessation in Adults Who Co-use Cannabis

Tobacco Use DisorderNicotine Dependence
Medical University of South Carolina105 enrolled3 locationsNCT06688539
Recruiting
Not Applicable

Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans

Lung Cancer ScreeningSmoking CessationTobacco Use Disorder
Louisiana State University Health Sciences Center in New Orleans250 enrolled2 locationsNCT07576595
Recruiting
Not Applicable

TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System

VapingSmoking, TobaccoTobacco Use Disorder+1 more
University of Zurich406 enrolled1 locationNCT07568483
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+8 more
Yale University200 enrolled2 locationsNCT06624137
Recruiting
Phase 4

Beta-Adrenergic Modulation of Drug Cue Reactivity

Tobacco Use DisorderNicotine DependenceCigarette Smoking
University of Oklahoma80 enrolled1 locationNCT05587361
Recruiting
Phase 2

Accelerated dTMS Smoking Cessation

Tobacco Use DisorderAddiction Nicotine
Waypoint Centre for Mental Health Care40 enrolled2 locationsNCT07292883
Recruiting
Phase 2

Cannabidiol for Reducing Cigarette Use

Tobacco Use DisorderTobacco DependenceTobacco Smoking
University of California, Los Angeles120 enrolled1 locationNCT06218056
Recruiting
Not Applicable

Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients

AnxietyTobacco Use DisorderNicotine Dependence+2 more
Chiao-Chiao Liao60 enrolled1 locationNCT07466875
Recruiting
Phase 3

Cannabis-Tobacco Co-Use Treatment Study

Tobacco Use DisorderTobacco Use CessationCannabis Use+2 more
Medical University of South Carolina200 enrolled1 locationNCT06883162
Recruiting
Phase 2

Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD

Tobacco Use Disorder
VA Office of Research and Development50 enrolled1 locationNCT05723588
Recruiting
Not Applicable

Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation

Tobacco Use Disorder
Centre Hospitalier Henri Laborit200 enrolled3 locationsNCT05766553
Recruiting
Phase 1

Oral Cannabidiol for Tobacco Cessation

Tobacco Use DisorderTobacco DependenceTobacco Use Cessation+2 more
Johns Hopkins University50 enrolled1 locationNCT05445804
Recruiting
Phase 4

Transcranial Magnetic Stimulation for Nicotine Dependence: An Effectiveness-Implementation Trial

Tobacco Use DisorderPsychiatric DisorderNicotine Dependence
Centre for Addiction and Mental Health40 enrolled1 locationNCT06534047
Recruiting
Phase 2

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

Smoking CessationTobacco Use Disorder
University of California, Los Angeles64 enrolled1 locationNCT06617312
Recruiting
Phase 2

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Tobacco Use Disorder
University of Missouri-Columbia30 enrolled1 locationNCT03713424
Recruiting
Not Applicable

Contingency Management for Veteran Smokers Undergoing Major Elective Surgery

Tobacco Use DisorderSubstance Use Disorder (SUD)
University of California, San Francisco36 enrolled1 locationNCT06678672
Recruiting
Not Applicable

Smoking Cessation CM for Veterans With or at Risk for Cancer

Tobacco Use DisorderSubstance Use Disorder
VA Office of Research and Development108 enrolled1 locationNCT06432985
Recruiting
Phase 4

tDCS Plus Varenicline for Smoking Cessation

Smoking CessationTobacco Use DisorderSubstance Use Disorders+3 more
Centre for Addiction and Mental Health160 enrolled1 locationNCT06798324
Recruiting
Phase 2

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Tobacco Use Disorder
Johns Hopkins University66 enrolled3 locationsNCT05452772